These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

669 related articles for article (PubMed ID: 33338412)

  • 1. PD-1-Expressing SARS-CoV-2-Specific CD8
    Rha MS; Jeong HW; Ko JH; Choi SJ; Seo IH; Lee JS; Sa M; Kim AR; Joo EJ; Ahn JY; Kim JH; Song KH; Kim ES; Oh DH; Ahn MY; Choi HK; Jeon JH; Choi JP; Kim HB; Kim YK; Park SH; Choi WS; Choi JY; Peck KR; Shin EC
    Immunity; 2021 Jan; 54(1):44-52.e3. PubMed ID: 33338412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SARS-CoV-2-specific T cell memory is sustained in COVID-19 convalescent patients for 10 months with successful development of stem cell-like memory T cells.
    Jung JH; Rha MS; Sa M; Choi HK; Jeon JH; Seok H; Park DW; Park SH; Jeong HW; Choi WS; Shin EC
    Nat Commun; 2021 Jun; 12(1):4043. PubMed ID: 34193870
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of IFNγ-Secreting CD4
    Matyushenko V; Isakova-Sivak I; Kudryavtsev I; Goshina A; Chistyakova A; Stepanova E; Prokopenko P; Sychev I; Rudenko L
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452355
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SARS-CoV-2 spike-specific nasal-resident CD49a
    Rha MS; Kim G; Lee S; Kim J; Jeong Y; Jung CM; Noh HE; Noh JY; Kim YM; Cho HJ; Kim CH; Shin EC
    Nat Commun; 2024 Sep; 15(1):8355. PubMed ID: 39333516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of pre-existing and induced SARS-CoV-2-specific CD8
    Schulien I; Kemming J; Oberhardt V; Wild K; Seidel LM; Killmer S; Sagar ; Daul F; Salvat Lago M; Decker A; Luxenburger H; Binder B; Bettinger D; Sogukpinar O; Rieg S; Panning M; Huzly D; Schwemmle M; Kochs G; Waller CF; Nieters A; Duerschmied D; Emmerich F; Mei HE; Schulz AR; Llewellyn-Lacey S; Price DA; Boettler T; Bengsch B; Thimme R; Hofmann M; Neumann-Haefelin C
    Nat Med; 2021 Jan; 27(1):78-85. PubMed ID: 33184509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic SARS-CoV-2-Specific Immunity in Critically Ill Patients With Hypertension.
    Zeng Q; Li YZ; Dong SY; Chen ZT; Gao XY; Zhang H; Huang G; Xu Y
    Front Immunol; 2020; 11():596684. PubMed ID: 33362779
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suboptimal SARS-CoV-2-specific CD8
    Habel JR; Nguyen THO; van de Sandt CE; Juno JA; Chaurasia P; Wragg K; Koutsakos M; Hensen L; Jia X; Chua B; Zhang W; Tan HX; Flanagan KL; Doolan DL; Torresi J; Chen W; Wakim LM; Cheng AC; Doherty PC; Petersen J; Rossjohn J; Wheatley AK; Kent SJ; Rowntree LC; Kedzierska K
    Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24384-24391. PubMed ID: 32913053
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2-specific CD8+ T cell responses in convalescent COVID-19 individuals.
    Kared H; Redd AD; Bloch EM; Bonny TS; Sumatoh H; Kairi F; Carbajo D; Abel B; Newell EW; Bettinotti MP; Benner SE; Patel EU; Littlefield K; Laeyendecker O; Shoham S; Sullivan D; Casadevall A; Pekosz A; Nardin A; Fehlings M; Tobian AA; Quinn TC
    J Clin Invest; 2021 Mar; 131(5):. PubMed ID: 33427749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenotypes and Functions of SARS-CoV-2-Reactive T Cells.
    Jung MK; Shin EC
    Mol Cells; 2021 Jun; 44(6):401-407. PubMed ID: 34120892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and characterization of a SARS-CoV-2 specific CD8
    Gangaev A; Ketelaars SLC; Isaeva OI; Patiwael S; Dopler A; Hoefakker K; De Biasi S; Gibellini L; Mussini C; Guaraldi G; Girardis M; Ormeno CMPT; Hekking PJM; Lardy NM; Toebes M; Balderas R; Schumacher TN; Ovaa H; Cossarizza A; Kvistborg P
    Nat Commun; 2021 May; 12(1):2593. PubMed ID: 33972535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 mutations in MHC-I-restricted epitopes evade CD8
    Agerer B; Koblischke M; Gudipati V; Montaño-Gutierrez LF; Smyth M; Popa A; Genger JW; Endler L; Florian DM; Mühlgrabner V; Graninger M; Aberle SW; Husa AM; Shaw LE; Lercher A; Gattinger P; Torralba-Gombau R; Trapin D; Penz T; Barreca D; Fae I; Wenda S; Traugott M; Walder G; Pickl WF; Thiel V; Allerberger F; Stockinger H; Puchhammer-Stöckl E; Weninger W; Fischer G; Hoepler W; Pawelka E; Zoufaly A; Valenta R; Bock C; Paster W; Geyeregger R; Farlik M; Halbritter F; Huppa JB; Aberle JH; Bergthaler A
    Sci Immunol; 2021 Mar; 6(57):. PubMed ID: 33664060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD8
    Nguyen THO; Rowntree LC; Petersen J; Chua BY; Hensen L; Kedzierski L; van de Sandt CE; Chaurasia P; Tan HX; Habel JR; Zhang W; Allen LF; Earnest L; Mak KY; Juno JA; Wragg K; Mordant FL; Amanat F; Krammer F; Mifsud NA; Doolan DL; Flanagan KL; Sonda S; Kaur J; Wakim LM; Westall GP; James F; Mouhtouris E; Gordon CL; Holmes NE; Smibert OC; Trubiano JA; Cheng AC; Harcourt P; Clifton P; Crawford JC; Thomas PG; Wheatley AK; Kent SJ; Rossjohn J; Torresi J; Kedzierska K
    Immunity; 2021 May; 54(5):1066-1082.e5. PubMed ID: 33951417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenic T cell epitopes of SARS-CoV-2 are recognized by circulating memory and naïve CD8 T cells of unexposed individuals.
    Quiros-Fernandez I; Poorebrahim M; Fakhr E; Cid-Arregui A
    EBioMedicine; 2021 Oct; 72():103610. PubMed ID: 34627082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional responsiveness of memory T cells from COVID-19 patients.
    Tavukcuoglu E; Horzum U; Cagkan Inkaya A; Unal S; Esendagli G
    Cell Immunol; 2021 Jul; 365():104363. PubMed ID: 33905951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IFN-γ
    Vallejo A; Vizcarra P; Quereda C; Moreno A; Casado JL;
    Eur J Clin Invest; 2021 Dec; 51(12):e13636. PubMed ID: 34164811
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impaired Priming of SARS-CoV-2-Specific Naive CD8
    Gallerani E; Proietto D; Dallan B; Campagnaro M; Pacifico S; Albanese V; Marzola E; Marconi P; Caputo A; Appay V; Gavioli R; Nicoli F
    Front Immunol; 2021; 12():693054. PubMed ID: 34326844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early induction of functional SARS-CoV-2-specific T cells associates with rapid viral clearance and mild disease in COVID-19 patients.
    Tan AT; Linster M; Tan CW; Le Bert N; Chia WN; Kunasegaran K; Zhuang Y; Tham CYL; Chia A; Smith GJD; Young B; Kalimuddin S; Low JGH; Lye D; Wang LF; Bertoletti A
    Cell Rep; 2021 Feb; 34(6):108728. PubMed ID: 33516277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunodominant Dengue Virus-Specific CD8+ T Cell Responses Are Associated with a Memory PD-1+ Phenotype.
    de Alwis R; Bangs DJ; Angelo MA; Cerpas C; Fernando A; Sidney J; Peters B; Gresh L; Balmaseda A; de Silva AD; Harris E; Sette A; Weiskopf D
    J Virol; 2016 May; 90(9):4771-4779. PubMed ID: 26912627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integrin Activation Enables Sensitive Detection of Functional CD4
    Schöllhorn A; Schuhmacher J; Besedovsky L; Fendel R; Jensen ATR; Stevanović S; Lange T; Rammensee HG; Born J; Gouttefangeas C; Dimitrov S
    Front Immunol; 2021; 12():626308. PubMed ID: 33854501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD8+PD-L1+CXCR3+ polyfunctional T cell abundances are associated with survival in critical SARS-CoV-2-infected patients.
    Adam L; Rosenbaum P; Quentric P; Parizot C; Bonduelle O; Guillou N; Corneau A; Dorgham K; Miyara M; Luyt CE; Guihot A; Gorochov G; Combadière C; Combadière B
    JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34283810
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.